BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3965499)

  • 1. Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases.
    Jacobs LR; Huber PW
    J Clin Invest; 1985 Jan; 75(1):112-8. PubMed ID: 3965499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lectin histochemistry in ulcerative colitis and Crohn's disease.
    Yoshioka H; Inada M; Ogawa K; Ohshio G; Yamabe H; Hamashima Y; Miyake T
    J Exp Pathol; 1989; 4(2):69-78. PubMed ID: 2769448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased production of vascular endothelial growth factor by intestinal mucosa of patients with inflammatory bowel disease.
    Griga T; Voigt E; Gretzer B; Brasch F; May B
    Hepatogastroenterology; 1999; 46(26):920-3. PubMed ID: 10370639
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regional differences in normal and cancer-associated glycoconjugates of the human colon.
    Bresalier RS; Boland CR; Kim YS
    J Natl Cancer Inst; 1985 Aug; 75(2):249-60. PubMed ID: 3927049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
    Griga T; May B; Pfisterer O; Müller KM; Brasch F
    Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationships between clinical data and histology of the large bowel in Crohn's disease and ulcerative colitis.
    Schmitz-Moormann P; Himmelmann GW; Brandes JW
    Pathol Annu; 1985; 20 Pt 1():281-301. PubMed ID: 3991239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
    Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
    Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thickness and continuity of the adherent colonic mucus barrier in active and quiescent ulcerative colitis and Crohn's disease.
    Strugala V; Dettmar PW; Pearson JP
    Int J Clin Pract; 2008 May; 62(5):762-9. PubMed ID: 18194279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
    Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
    Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein composition of colonic mucosa. Specific alterations in ulcerative colitis.
    Podolsky DK; Isselbacher KJ
    Gastroenterology; 1984 Nov; 87(5):991-8. PubMed ID: 6090262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of VEGF and CD146 in patients with inflammatory bowel disease.
    Tsiolakidou G; Koutroubakis IE; Tzardi M; Kouroumalis EA
    Dig Liver Dis; 2008 Aug; 40(8):673-9. PubMed ID: 18374637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of 1H magnetic resonance spectroscopy in inflammatory bowel diseases: distinguishing ulcerative colitis from Crohn's disease.
    Bezabeh T; Somorjai RL; Smith IC; Nikulin AE; Dolenko B; Bernstein CN
    Am J Gastroenterol; 2001 Feb; 96(2):442-8. PubMed ID: 11232688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in the immunohistochemical expression of Das-1 and CG-3 in colonic mucosal biopsy specimens helps distinguish ulcerative colitis from Crohn disease and from other forms of colitis.
    Yantiss RK; Das KM; Farraye FA; Odze RD
    Am J Surg Pathol; 2008 Jun; 32(6):844-50. PubMed ID: 18408596
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lectin UEA-I-binding proteins are specifically increased in the squamous epithelium of patients with Barrett's esophagus.
    Neumann H; Wex T; Mönkemüller K; Vieth M; Fry LC; Malfertheiner P
    Digestion; 2008; 78(4):201-7. PubMed ID: 19129702
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease-related lesions in the duodenal and gastric mucosa.
    Danelius M; Ost A; Lapidus AB
    Scand J Gastroenterol; 2009; 44(4):441-5. PubMed ID: 19110988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S; Florin TH; Khalil D; Zhang MF; Patel K; Hamilton I; Hart DN
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal imbalance of IL-1 and IL-1 receptor antagonist in inflammatory bowel disease. A novel mechanism of chronic intestinal inflammation.
    Casini-Raggi V; Kam L; Chong YJ; Fiocchi C; Pizarro TT; Cominelli F
    J Immunol; 1995 Mar; 154(5):2434-40. PubMed ID: 7868909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lectin binding in colorectal mucosa.
    Shah M; Shrikhande SS; Swaroop VS
    Indian J Gastroenterol; 1989 Jan; 8(1):31-3. PubMed ID: 2914716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Indications for different collagen metabolism in Crohn disease and ulcerative colitis].
    Matthes H; Stallmach A; Matthes B; Herbst H; Schuppan D; Riecken EO
    Med Klin (Munich); 1993 Apr; 88(4):185-92. PubMed ID: 8492773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.